bpc 157 case study BPC-157 and Healing Peptides: Hype or Hope? A Doctor's Comprehensive Perspective – MSK Doctor Zaid Matti BPC-157 and the Difference Between

[DOI] [PMC free article] [PubMed] [Google Scholar] 62.Sikiric P, Separovic J, Anic T, Buljat G, Mikus D, Seiwerth S, Grabarevic Z, Stancic-Rokotov D, Pigac B, Hanzevacki M, Marovic A, Rucman R, Petek M, Zoricic I, Ziger T, Aralica G, Konjevoda P, Prkacin I, Gjurasin M, Miklic P, Artukovic B, Tisljar M, Bratulic M, Mise S, Rotkvic I

Pentadecapeptide BPC 157 and its Effects on a NSAID Toxicity Model: Diclofenacinducedgastrointestinal, Liver, and Encephalopathy Lesions

The TAS level was found to be significantly lower in the IR group compared to the control and BPC-applied groups ( p = 0.002, p = 0.034, respectively)

The BPC-157 and TB-500 combination represents the gold standard approach for muscular back pain